Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CoCensys initiates migraine trial

March 5, 1997

Gamma-hydroxybutyrate associated with dependence liability

March 4, 1997

Sustained-release methylphenidate for HIV-associated cognitive impairment

March 4, 1997

Gliatech receives grant for histamine H3 receptor antagonists

March 3, 1997

Novel polyamines fromTeva

March 3, 1997

NeoTherapeutics seeks approval for trials on neurological drug

Feb. 28, 1997

MS&D describes nonpeptide tachykinin antagonists

Feb. 28, 1997

Sigma-receptor antagonists disclosed by Taisho

Feb. 28, 1997

Taiho discloses anxiolytics

Feb. 28, 1997

Riluzole now available in France

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...